Next Article in Journal
Therapeutic Use of Valproic Acid and All-Trans Retinoic Acid in Acute Myeloid Leukemia—Literature Review and Discussion of Possible Use in Relapse after Allogeneic Stem Cell Transplantation
Next Article in Special Issue
Synthesis and Anticancer Evaluation of New 1,3,4-Oxadiazole Derivatives
Previous Article in Journal
ICG-001, an Inhibitor of the β-Catenin and cAMP Response Element-Binding Protein Dependent Gene Transcription, Decreases Proliferation but Enhances Migration of Osteosarcoma Cells
Previous Article in Special Issue
Mechanistic Modelling Identifies and Addresses the Risks of Empiric Concentration-Guided Sorafenib Dosing
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceuticals
Volume 14
Issue 5
10.3390/ph14050422
pharmaceuticals-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Design, Synthesis, and Molecular Docking Study of New Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors Combining Resin Acids and Adamantane Moieties

by
Kseniya Kovaleva
1,
Olga Yarovaya
1,2,*,
Konstantin Ponomarev
1,
Sergey Cheresiz
2,
Amirhossein Azimirad
2,
Irina Chernyshova
2,
Alexandra Zakharenko
3,
Vasily Konev
4,
Tatiana Khlebnikova
4,
Evgenii Mozhaytsev
1,
Evgenii Suslov
1,
Dmitry Nilov
5,
Vytas Švedas
5,6,
Andrey Pokrovsky
2,
Olga Lavrik
2,3 and
Nariman Salakhutdinov
1
1
N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, Lavrentiev Ave. 9, 630090 Novosibirsk, Russia
2
V. Zelman Institute for the Medicine and Psychology, Novosibirsk State University, Pirogova St. 1, 630090 Novosibirsk, Russia
3
Novosibirsk Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Lavrentiev Ave. 8, 630090 Novosibirsk, Russia
4
Boreskov Institute of Catalysis, Siberian Branch of the Russian Academy of Sciences, Lavrentiev Ave. 5, 630090 Novosibirsk, Russia
5
Belozersky Institute of Physicochemical Biology, Lomonosov Moscow State University, Lenin Hills 1, Bldg. 40, 119991 Moscow, Russia
6
Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Lenin Hills 1, Bldg. 73, 119991 Moscow, Russia
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2021, 14(5), 422; https://doi.org/10.3390/ph14050422
Submission received: 26 March 2021 / Revised: 22 April 2021 / Accepted: 23 April 2021 / Published: 1 May 2021
(This article belongs to the Special Issue Anticancer Drugs 2021)
Browse Figures
Review Reports Versions Notes

Abstract

In this paper, a series of novel abietyl and dehydroabietyl ureas, thioureas, amides, and thioamides bearing adamantane moieties were designed, synthesized, and evaluated for their inhibitory activities against tyrosil-DNA-phosphodiesterase 1 (TDP1). The synthesized compounds were able to inhibit TDP1 at micromolar concentrations (0.19–2.3 µM) and demonstrated low cytotoxicity in the T98G glioma cell line. The effect of the terpene fragment, the linker structure, and the adamantane residue on the biological properties of the new compounds was investigated. Based on molecular docking results, we suppose that adamantane derivatives of resin acids bind to the TDP1 covalent intermediate, forming a hydrogen bond with Ser463 and hydrophobic contacts with the Phe259 and Trp590 residues and the oligonucleotide fragment of the substrate.
Keywords: tyrosil-DNA-phosphodiesterase 1; adamantane; resin acid; TDP1 tyrosil-DNA-phosphodiesterase 1; adamantane; resin acid; TDP1
Graphical Abstract

Share and Cite

MDPI and ACS Style

Kovaleva, K.; Yarovaya, O.; Ponomarev, K.; Cheresiz, S.; Azimirad, A.; Chernyshova, I.; Zakharenko, A.; Konev, V.; Khlebnikova, T.; Mozhaytsev, E.; et al. Design, Synthesis, and Molecular Docking Study of New Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors Combining Resin Acids and Adamantane Moieties. Pharmaceuticals 2021, 14, 422. https://doi.org/10.3390/ph14050422

AMA Style

Kovaleva K, Yarovaya O, Ponomarev K, Cheresiz S, Azimirad A, Chernyshova I, Zakharenko A, Konev V, Khlebnikova T, Mozhaytsev E, et al. Design, Synthesis, and Molecular Docking Study of New Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors Combining Resin Acids and Adamantane Moieties. Pharmaceuticals. 2021; 14(5):422. https://doi.org/10.3390/ph14050422

Chicago/Turabian Style

Kovaleva, Kseniya, Olga Yarovaya, Konstantin Ponomarev, Sergey Cheresiz, Amirhossein Azimirad, Irina Chernyshova, Alexandra Zakharenko, Vasily Konev, Tatiana Khlebnikova, Evgenii Mozhaytsev, and et al. 2021. "Design, Synthesis, and Molecular Docking Study of New Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors Combining Resin Acids and Adamantane Moieties" Pharmaceuticals 14, no. 5: 422. https://doi.org/10.3390/ph14050422

APA Style

Kovaleva, K., Yarovaya, O., Ponomarev, K., Cheresiz, S., Azimirad, A., Chernyshova, I., Zakharenko, A., Konev, V., Khlebnikova, T., Mozhaytsev, E., Suslov, E., Nilov, D., Švedas, V., Pokrovsky, A., Lavrik, O., & Salakhutdinov, N. (2021). Design, Synthesis, and Molecular Docking Study of New Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors Combining Resin Acids and Adamantane Moieties. Pharmaceuticals, 14(5), 422. https://doi.org/10.3390/ph14050422

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop